
Borosil Scientific Q2FY27: PAT +86% YoY to ₹5.3 Cr, margin expands as pharma losses narrow
lab glass equipment · pharma packaging · margin expansion
BSE: 544184
P/L Snapshot
Q2 FY27 · standalone
Shareholding
Pattern breakdown
P/L Trends
(in crores)
Corporate Events
Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗Board Meeting
The Annual General Meeting (AGM) is scheduled to be held on …
BSE Filing ↗Board Meeting
The Board of Directors approved the proposal for expansion o…
BSE Filing ↗Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗Board Meeting
consider and approve the Unaudited Financial Results (Standa…
BSE Filing ↗Board Meeting
Board Meeting Intimation, Unaudited Financial Results (Stand…
BSE Filing ↗Board Meeting
Consider and approve Unaudited Financial Results
BSE Filing ↗Board Meeting
Consider and approve the Unaudited Standalone & Consolidated…
BSE Filing ↗Board Meeting
Consider and approve Unaudited Standalone & Consolidated Fin…
BSE Filing ↗